• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[系统性红斑狼疮的治疗策略]

[Therapeutic strategies for systemic lupus erythematosus].

作者信息

Schneider M

机构信息

Poliklinik und Funktionsbereich für Rheumatologie UKD, Heinrich-Heine-Universität Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland,

出版信息

Z Rheumatol. 2015 Apr;74(3):199-205. doi: 10.1007/s00393-014-1457-1.

DOI:10.1007/s00393-014-1457-1
PMID:25854154
Abstract

Therapeutic strategy means the definition of a long-term target, which should be reached by a chosen management. As for rheumatoid arthritis, the treat to target initiative recommends remission as the target for systemic lupus erythematosus (SLE) but the command variables of remission are not yet defined. The basis of a therapeutic strategy is first the analysis of those factors that may influence the achievement of the objectives: SLE disease activity, the differentiation of damage, organ manifestations, comorbidities, genetics, sex, age of onset and considering the pathophysiological basis are some of these factors. The next step is the analysis of the available substances and concepts that allow the target to be reached. Finally, rules for management (e.g. guidelines) are needed that enrich the possibility to reach the target and improve the prognosis of patients suffering from SLE.

摘要

治疗策略是指确定一个长期目标,该目标应由选定的治疗方案来实现。对于类风湿性关节炎,“达标治疗”倡议推荐将缓解作为系统性红斑狼疮(SLE)的治疗目标,但缓解的控制变量尚未明确。治疗策略的基础首先是分析那些可能影响目标实现的因素:SLE疾病活动度、损伤的分化、器官表现、合并症、遗传学、性别、发病年龄,而考虑病理生理基础也是其中一些因素。下一步是分析可用于实现目标的现有药物和理念。最后,需要管理规则(如指南),以增加实现目标的可能性,并改善SLE患者的预后。

相似文献

1
[Therapeutic strategies for systemic lupus erythematosus].[系统性红斑狼疮的治疗策略]
Z Rheumatol. 2015 Apr;74(3):199-205. doi: 10.1007/s00393-014-1457-1.
2
[Disseminated lupus erythematosus in children: guidelines about investigations during the initial evaluation and follow-up].[儿童播散性红斑狼疮:初始评估及随访期间的检查指南]
Arch Pediatr. 2004 Aug;11(8):941-4. doi: 10.1016/j.arcped.2004.01.027.
3
Treat to target in systemic lupus erythematosus: a commentary.系统性红斑狼疮的达标治疗:一篇评论
Clin Rheumatol. 2016 Aug;35(8):1903-1907. doi: 10.1007/s10067-016-3346-2. Epub 2016 Jul 12.
4
Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.在临床试验、长期观察性研究和临床护理中评估系统性红斑狼疮患者的指标。
Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-85-95. Epub 2014 Oct 30.
5
[Advances and prospects in the treatment of systemic lupus erythematosus].[系统性红斑狼疮治疗的进展与展望]
Ter Arkh. 2009;81(12):44-7.
6
Outcome measures to be used in clinical trials in systemic lupus erythematosus.系统性红斑狼疮临床试验中使用的结局指标。
J Rheumatol. 1999 Feb;26(2):490-7.
7
[Lupus erythematosus - Update 2016].[红斑狼疮 - 2016年更新]
Dtsch Med Wochenschr. 2016 Nov;141(24):1785-1788. doi: 10.1055/s-0042-117085. Epub 2016 Nov 30.
8
[Systemic lupus erythematosus. Target criteria for treatment].
Z Rheumatol. 2009 Feb;68(1):23-9. doi: 10.1007/s00393-008-0359-5.
9
Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study.青少年起病型混合性结缔组织病的长期转归:一项全国性挪威研究。
Ann Rheum Dis. 2017 Jan;76(1):159-165. doi: 10.1136/annrheumdis-2016-209522. Epub 2016 Jun 9.
10
Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.与类风湿关节炎相比,系统性红斑狼疮的医疗保健与疾病负担:来自德国协作关节炎中心国家数据库的结果
Lupus. 2004;13(7):529-36. doi: 10.1191/0961203304lu1054oa.

本文引用的文献

1
Understanding remission in real-world lupus patients across five European countries.了解五个欧洲国家现实世界中狼疮患者的缓解情况。
Lupus. 2016 Apr;25(5):505-12. doi: 10.1177/0961203315619030. Epub 2015 Dec 2.
2
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.系统性红斑狼疮患者损伤累积的相关因素:来自系统性红斑狼疮国际协作临床研究(SLICC)初始队列的结果。
Ann Rheum Dis. 2015 Sep;74(9):1706-13. doi: 10.1136/annrheumdis-2013-205171. Epub 2014 May 16.
3
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.
靶向治疗系统性红斑狼疮:国际工作组的建议。
Ann Rheum Dis. 2014 Jun;73(6):958-67. doi: 10.1136/annrheumdis-2013-205139. Epub 2014 Apr 16.
4
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.EULAR 推荐的治疗类风湿关节炎的合成和生物疾病修饰抗风湿药物:2013 更新版。
Ann Rheum Dis. 2014 Mar;73(3):492-509. doi: 10.1136/annrheumdis-2013-204573. Epub 2013 Oct 25.
5
Anti-interferon alpha treatment in SLE.系统性红斑狼疮的抗干扰素 α 治疗。
Clin Immunol. 2013 Sep;148(3):303-12. doi: 10.1016/j.clim.2013.02.013. Epub 2013 Mar 1.
6
Cytokine inhibition as a strategy for treating systemic lupus erythematosus.细胞因子抑制作为治疗系统性红斑狼疮的策略。
Clin Immunol. 2013 Sep;148(3):335-43. doi: 10.1016/j.clim.2012.11.001. Epub 2012 Nov 12.
7
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.欧洲抗风湿病联盟和欧洲肾脏协会-欧洲透析和移植协会(EULAR/ERA-EDTA)成人和儿童狼疮肾炎管理建议。
Ann Rheum Dis. 2012 Nov;71(11):1771-82. doi: 10.1136/annrheumdis-2012-201940. Epub 2012 Jul 31.
8
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.美国风湿病学会/欧洲抗风湿病联盟类风湿关节炎临床试验缓解的临时定义。
Ann Rheum Dis. 2011 Mar;70(3):404-13. doi: 10.1136/ard.2011.149765.
9
Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases.生物标志物在转化研究中的临床相关性的有效性:以系统性自身免疫性疾病为例。
Arthritis Res Ther. 2010;12(5):R179. doi: 10.1186/ar3143. Epub 2010 Sep 27.
10
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs.EULAR 推荐的伴有神经精神表现的系统性红斑狼疮的管理:EULAR 常务委员会临床事务工作组的报告。
Ann Rheum Dis. 2010 Dec;69(12):2074-82. doi: 10.1136/ard.2010.130476. Epub 2010 Aug 19.